SCHEMBL10273855

SCHEMBL10273855

O=C(CCl)NNc1ccc2c(n1)NC(c1ccccc1)C(=O)N2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.44
MAPT P10636 4/20 0.44
GAA P10253 3/20 0.44
HPGD P15428 1/20 0.44
AGTR1 P30556 1/20 0.44
XIAP P98170 2/20 0.38
BIRC2 Q13490 2/20 0.38
KDM4E B2RXH2 5/20 0.34
LMNA P02545 4/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
RAB9A P51151 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
BLM P54132 1/20 0.32
PLEC Q15149 1/20 0.32
IDO1 P14902 1/20 0.32
TDO2 P48775 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9109997 0.74 NOS1 (0.38) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL9108518 0.66 GSK3B (0.49) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL9109613 0.66 GSK3B (0.49) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL9109620 0.66 GSK3B (0.49) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL1559670 0.63 ALDH1A1 (0.45) ALDH1A1MAPTGAAHPGDAGTR1
SCHEMBL2361451 0.63 KDM4E (0.57) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL17854806 0.61 XIAP (0.55) ALDH1A1MAPTGAAXIAPBIRC2
SCHEMBL31038410 0.60 ALDH1A1 (0.53) ALDH1A1MAPTGAALMNAMEN1
SCHEMBL1458967 0.60 ALDH1A1 (0.53) ALDH1A1MAPTGAALMNAMEN1
SCHEMBL31738422 0.59 TDP1 (0.66) ALDH1A1MAPTGAAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207169-B2 Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D MSD K.K. (JP) 2012-06-26 US disclosed
US-20110092511-A1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME LLC 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092511-A1 INHIBITORS OF AKT ACTIVITY AKT1S1, AKT1, PIK3CA ALDH1A1 4132/4885MAPT 4425/4885GAA 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.